Chembio Diagnostics, Inc. (CEMID) - Product Pipeline Analysis

Chembio Diagnostics, Inc. (CEMID) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide73 Pages Price :
$ 750

Chembio Diagnostics, Inc. (Chembio) together with its wholly owned subsidiary Chembio Diagnostic Systems, Inc., undertakes the development, manufacturing and marketing of point-of-care diagnostic (POCs) tests that detect infectious diseases. The major commercially available products of the company include four rapid tests for the detection of HIV antibodies, two rapid tests for the detection of syphilis and a rapid test for the detection of canine leishmaniasis. Its new product pipeline is based on Dual Path Platform (DPP) technology. The company offers its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals and retailers. Chembio is headquartered in Medford, the US.

This report is a source for data, analysis and actionable intelligence on the Chembio Diagnostics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 6
Chembio Diagnostics, Inc. - Business Description 7

Key Facts 8
Chembio Diagnostics, Inc. - Major Products and Services 9
Chembio Diagnostics, Inc. Pipeline Products by Equipment Type 10
Chembio Diagnostics, Inc. Pipeline Products by Development Stage 12
Chembio Diagnostics, Inc. Pipeline Products by Therapy Area 14
Chembio Diagnostics, Inc. Pipeline Products by Trial Phase 16
Chembio Diagnostics, Inc. Pipeline Products by Milestone Summary 18
Battelle/CDC DPP Influenza Immunity Test 20
Battelle/CDC DPP Influenza Immunity Test Product Status 20
Battelle/CDC DPP Influenza Immunity Test Product Description 20
Battelle/CDC DPP Influenza Immunity Test Product Patent Details 20
Clearview HIV 1/2 STAT PAK Assay 22
Clearview HIV 1/2 STAT PAK Assay Product Status 22
Clearview HIV 1/2 STAT PAK Assay Product Description 22
Clearview HIV 1/2 STAT PAK Assay Clinical Trial 22
DPP Hepatitis C Virus Assay 24
DPP Hepatitis C Virus Assay Product Status 24
DPP Hepatitis C Virus Assay Product Description 24
DPP HIV 1/2 Screening Assay 25
DPP HIV 1/2 Screening Assay Product Status 25
DPP HIV 1/2 Screening Assay Product Description 25
DPP HIV 1/2 Screening Assay Product Milestone 25
DPP HIV 1/2 Screening Assay Clinical Trial 26
DPP HIV 1/2 Screening Assay Product Patent Details 28
DPP HIV/HCV Combo Oral Fluid Assay 36
DPP HIV/HCV Combo Oral Fluid Assay Product Status 36
DPP HIV/HCV Combo Oral Fluid Assay Product Description 36
DPP Influenza A/B Assay 37
DPP Influenza A/B Assay Product Status 37
DPP Influenza A/B Assay Product Description 37
DPP Leptospirosis Test 38
DPP Leptospirosis Test Product Status 38
DPP Leptospirosis Test Product Description 38
DPP Syphilis Screen And Confirm Test 39
DPP Syphilis Screen And Confirm Test Product Status 39
DPP Syphilis Screen And Confirm Test Product Description 39
DPP Syphilis Screen And Confirm Test Product Milestone 39
DPP Syphilis Screen And Confirm Test Clinical Trial 40
DPP Syphilis Screen And Confirm Test Product Patent Details 41
DPP Tuberculosis Assay 50
DPP Tuberculosis Assay Product Status 50
DPP Tuberculosis Assay Product Description 50
DPP Tuberculosis Assay Product Milestone 50
DPP Tuberculosis Assay Product Patent Details 51
Sure Check Rapid HIV Test 60
Sure Check Rapid HIV Test Product Status 60
Sure Check Rapid HIV Test Product Description 60
Sure Check Rapid HIV Test Product Milestone 60
Chembio Diagnostics, Inc. - Key Competitors 62
Chembio Diagnostics, Inc. - Key Employees 63
Chembio Diagnostics, Inc. - Key Employee Biographies 64
Chembio Diagnostics, Inc. - Locations And Subsidiaries 65
Head Office 65
Other Locations & Subsidiaries 65
Recent Developments 66
Chembio Diagnostics, Inc., Recent Developments 66
Jul 16, 2012: Chembio To Exhibit At 2012 AACC Annual Meeting And Clinical Lab Expo 66
Jun 06, 2012: Chembio Approved For Listing On NASDAQ 66
May 08, 2012: Chembio Reports Revenue Of $6.7m In Q1 2012 66
May 08, 2012: Chembio Reports Revenue Of $19.4m In 2011 67
Nov 03, 2011: Chembio Reports Revenues Of $5.9m In Q3 2011 69
Oct 19, 2011: Chembio To Expand Patent Protection For Dual Path Platform Technology 70
Aug 04, 2011: Chembio Reports Total Revenues Of $3.6m In Q2 2011 70
Jun 21, 2011: Chembio Appoints Barbara DeBuono And Peter Kissinger To Board Of Directors 71
May 05, 2011: Chembio Reports Total Revenues Of $3.6m In Q1 2011 71
Mar 03, 2011: Chembio Reports Net Income Of $2.5m In 2010 72

Appendix 73
Methodology 73
About GlobalData 73
Contact Us 73
Disclaimer 73

List of Table


Chembio Diagnostics, Inc., Key Facts 1
Chembio Diagnostics, Inc. Key Pipeline Products by Equipment Type 1
Chembio Diagnostics, Inc. Key Pipeline Products by Therapy Area 1
Chembio Diagnostics, Inc. Key Pipeline Products by Development Stage 1
Chembio Diagnostics, Inc. Key Pipeline Products by Trial Phase 1
Chembio Diagnostics, Inc., Key Facts 8
Chembio Diagnostics, Inc., Major Products and Services 9
Chembio Diagnostics, Inc. Number of Pipeline Products by Equipment Type 10
Chembio Diagnostics, Inc. Pipeline Products by Equipment Type 11
Chembio Diagnostics, Inc. Number of Pipeline Products by Development Stage 12
Chembio Diagnostics, Inc. Pipeline Products by Development Stage 13
Chembio Diagnostics, Inc. Number of Pipeline Products by Therapy Area 14
Chembio Diagnostics, Inc. Pipeline Products by Therapy Area 15
Chembio Diagnostics, Inc. Number of Pipeline Products by Trial Phase 16
Chembio Diagnostics, Inc. Pipeline Products by Trial Phase 17
Chembio Diagnostics, Inc. Number of Pipeline Products By Milestone Summary 18
Chembio Diagnostics, Inc. Pipeline Products by Milestone Summary 19
Battelle/CDC DPP Influenza Immunity Test - Product Status 20
Battelle/CDC DPP Influenza Immunity Test - Product Description 20
Battelle/CDC DPP Influenza Immunity Test - Patent Details1 20
Battelle/CDC DPP Influenza Immunity Test - Patent Details2 21
Clearview HIV 1/2 STAT PAK Assay - Product Status 22
Clearview HIV 1/2 STAT PAK Assay - Product Description 22
Clearview HIV 1/2 STAT PAK Assay - Clinical Sensitivity of the Clearview COMPLETE HIV 1/2, PMA # BP050009 and the Clearview HIV 1/2 STAT-PAK, PMA #BP050010 in the 12 - 17 Year Old Pediatric Population 22
DPP Hepatitis C Virus Assay - Product Status 24
DPP Hepatitis C Virus Assay - Product Description 24
DPP HIV 1/2 Screening Assay - Product Status 25
DPP HIV 1/2 Screening Assay - Product Description 25
DPP HIV 1/2 Screening Assay - Product Milestone 25
DPP HIV 1/2 Screening Assay - Study to Establish the Ability of the Chembio Diagnostics Systems, Inc. DPP HIV 1/2 Rapid Test to Qualitatively Detect the Presence of Antibodies Against HIV-1 in Oral Fluid, Whole Blood (Capillary and Venous), Serum and Plasma 26
DPP HIV 1/2 Screening Assay - Patent Details1 28
DPP HIV 1/2 Screening Assay - Patent Details2 28
DPP HIV 1/2 Screening Assay - Patent Details3 29
DPP HIV 1/2 Screening Assay - Patent Details4 29
DPP HIV 1/2 Screening Assay - Patent Details5 30
DPP HIV 1/2 Screening Assay - Patent Details6 31
DPP HIV 1/2 Screening Assay - Patent Details7 31
DPP HIV 1/2 Screening Assay - Patent Details8 32
DPP HIV 1/2 Screening Assay - Patent Details9 32
DPP HIV 1/2 Screening Assay - Patent Details10 33
DPP HIV 1/2 Screening Assay - Patent Details11 33
DPP HIV 1/2 Screening Assay - Patent Details12 34
DPP HIV 1/2 Screening Assay - Patent Details13 34
DPP HIV 1/2 Screening Assay - Patent Details14 35
DPP HIV/HCV Combo Oral Fluid Assay - Product Status 36
DPP HIV/HCV Combo Oral Fluid Assay - Product Description 36
DPP Influenza A/B Assay - Product Status 37
DPP Influenza A/B Assay - Product Description 37
DPP Leptospirosis Test - Product Status 38
DPP Leptospirosis Test - Product Description 38
DPP Syphilis Screen And Confirm Test - Product Status 39
DPP Syphilis Screen And Confirm Test - Product Description 39
DPP Syphilis Screen And Confirm Test - Product Milestone 39
DPP Syphilis Screen And Confirm Test - Qualitative Evaluation of the DPP Syphilis Screen and Confirm Rapid Test to Detect the Presence of Antibodies Against Non-Treponemal and Treponema Pallidum Antigens in Fingerstick Whole Blood, Venous Whole Blood, Serum and Plasma Specimens 40
DPP Syphilis Screen And Confirm Test - Patent Details1 41
DPP Syphilis Screen And Confirm Test - Patent Details2 42
DPP Syphilis Screen And Confirm Test - Patent Details3 42
DPP Syphilis Screen And Confirm Test - Patent Details4 43
DPP Syphilis Screen And Confirm Test - Patent Details5 43
DPP Syphilis Screen And Confirm Test - Patent Details6 44
DPP Syphilis Screen And Confirm Test - Patent Details7 45
DPP Syphilis Screen And Confirm Test - Patent Details8 45
DPP Syphilis Screen And Confirm Test - Patent Details9 46
DPP Syphilis Screen And Confirm Test - Patent Details10 46
DPP Syphilis Screen And Confirm Test - Patent Details11 47
DPP Syphilis Screen And Confirm Test - Patent Details12 47
DPP Syphilis Screen And Confirm Test - Patent Details13 48
DPP Syphilis Screen And Confirm Test - Patent Details14 48
DPP Tuberculosis Assay - Product Status 50
DPP Tuberculosis Assay - Product Description 50
DPP Tuberculosis Assay - Product Milestone 50
DPP Tuberculosis Assay - Patent Details1 51
DPP Tuberculosis Assay - Patent Details2 52
DPP Tuberculosis Assay - Patent Details3 52
DPP Tuberculosis Assay - Patent Details4 53
DPP Tuberculosis Assay - Patent Details5 54
DPP Tuberculosis Assay - Patent Details6 54
DPP Tuberculosis Assay - Patent Details7 55
DPP Tuberculosis Assay - Patent Details8 55
DPP Tuberculosis Assay - Patent Details9 56
DPP Tuberculosis Assay - Patent Details10 57
DPP Tuberculosis Assay - Patent Details11 57
DPP Tuberculosis Assay - Patent Details12 57
DPP Tuberculosis Assay - Patent Details13 58
DPP Tuberculosis Assay - Patent Details14 59
Sure Check Rapid HIV Test - Product Status 60
Sure Check Rapid HIV Test - Product Description 60
Sure Check Rapid HIV Test - Product Milestone 60
Chembio Diagnostics, Inc., Key Employees 63
Chembio Diagnostics, Inc., Key Employee Biographies 64
Chembio Diagnostics, Inc., Subsidiaries 65

List of Chart


Chembio Diagnostics, Inc. Pipeline Products by Equipment Type 10
Chembio Diagnostics, Inc. Pipeline Products by Development Stage 12
Chembio Diagnostics, Inc. Pipeline Products by Therapy Area 14
Chembio Diagnostics, Inc. Pipeline Products by Trial Phase 16
Chembio Diagnostics, Inc. Pipeline Products by Milestone Summary 18

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top